M2 Proton Channel Inhibitor Pharmacokinetics
From Proteopedia
(Difference between revisions)
(New page: {| class="wikitable" border="1" width="45%" style="text-align:center" |- ! colspan="7" align="center"| M2 Proton Channel Inhibitor Pharmacokinetics |- ! Parameter ! Rimantadine !...) |
|||
| Line 1: | Line 1: | ||
| - | {| class="wikitable" border="1" width=" | + | {| class="wikitable" border="1" width="100%" style="text-align:center" |
|- | |- | ||
! colspan="7" align="center"| M2 Proton Channel Inhibitor [[Pharmacokinetics]] | ! colspan="7" align="center"| M2 Proton Channel Inhibitor [[Pharmacokinetics]] | ||
Current revision
| M2 Proton Channel Inhibitor Pharmacokinetics | ||||||
|---|---|---|---|---|---|---|
| Parameter | Rimantadine | Amantadine | ||||
| Tmax (hr) | 4.3 | 2.5 | ||||
| Cmax (ng/ml) | 310 | 402 | ||||
| Bioavailability (%) | >90 | >90 | ||||
| Protein Binding (%) | 40 | 67 | ||||
| T1/2 (hr) | 27.7 | ~15 | ||||
| AUC (ng/ml/hr) | 11917 | 5420 | ||||
| Dosage (mg) | 100 | 100 | ||||
| Metabolism | Negligible | Negligible | ||||
For Pharmacokinetic Data References, See: References
